About Caliper Life Sciences
Caliper Life Sciences is a company based in Hopkinton (United States) founded in 1995 by Larry Bock was acquired by PerkinElmer in September 2011. Caliper Life Sciences has completed 1 acquisition, including Xenogen. Caliper Life Sciences operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
- Headquarter Hopkinton, United States
- Founders Larry Bock
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Caliper Life Sciences, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
PerkinElmer
(Sep 08, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Caliper Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Caliper Life Sciences
Investors in Caliper Life Sciences
Caliper Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked |
Investor details for Caliper Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caliper Life Sciences
Caliper Life Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xenogen.
Investment portfolio details for Caliper Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of in vivo drug development solutions
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for Caliper Life Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Caliper Life Sciences
Detailed financials for Caliper Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caliper Life Sciences Comparisons
Peer comparison for Caliper Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caliper Life Sciences
Caliper Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Diversified instruments are developed for scientific and laboratory management.
|
Detailed competitors of Caliper Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caliper Life Sciences
Complete news archive for Caliper Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caliper Life Sciences
Caliper Life Sciences was founded in 1995.
Caliper Life Sciences is headquartered in Hopkinton, United States. It is registered at Hopkinton, Massachusetts, United States.
Caliper Life Sciences was founded in 1995 in Hopkinton, United States, as a biotech firm focused on drug development tools. Microfluidic lab-on-a-chip systems were pioneered early, alongside reagents, detection technologies, imaging equipment, sample preparation tools, and informatics software. Contract research services support biopharma operations. Biophotonic imaging capabilities were integrated after acquiring Xenogen. The company was purchased by PerkinElmer in 2011 for USD 600 million.
Caliper Life Sciences's top competitors include Cepheid, Blackrock Neurotech and Agilent.
Caliper Life Sciences has made 1 acquisition, including Xenogen.
Caliper Life Sciences has 1 investor. Key investors include PerkinElmer.